| Nome |
# |
|
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond, file e27ce430-aefb-2581-e053-d805fe0acbaa
|
623
|
|
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands, file e27ce427-03de-2581-e053-d805fe0acbaa
|
500
|
|
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines., file e27ce426-e6f6-2581-e053-d805fe0acbaa
|
343
|
|
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer, file e27ce428-b1cc-2581-e053-d805fe0acbaa
|
336
|
|
Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples, file e27ce42b-f44d-2581-e053-d805fe0acbaa
|
262
|
|
Lobular breast cancer: Histomorphology and different concepts of a special spectrum of tumors, file e27ce432-936e-2581-e053-d805fe0acbaa
|
261
|
|
CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples, file e27ce42e-a078-2581-e053-d805fe0acbaa
|
254
|
|
Personalized therapeutic strategies in HER2-driven gastric cancer, file e27ce432-5232-2581-e053-d805fe0acbaa
|
238
|
|
The perfect pathology report after neoadjuvant therapy, file e27ce427-33ec-2581-e053-d805fe0acbaa
|
224
|
|
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis, file e27ce426-fe1a-2581-e053-d805fe0acbaa
|
213
|
|
“To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer, file e27ce426-f0e6-2581-e053-d805fe0acbaa
|
209
|
|
Classification of pulmonary neuroendocrine tumors: New insights, file e27ce42d-471e-2581-e053-d805fe0acbaa
|
202
|
|
Distinctive pathological and clinical features of lung carcinoids with high proliferation index, file e27ce42b-cc7b-2581-e053-d805fe0acbaa
|
201
|
|
Pleomorphism of the Nuclear Envelope in breast cancer: a new approach to an old problem, file e27ce42b-692e-2581-e053-d805fe0acbaa
|
198
|
|
Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices, file e27ce42e-b633-2581-e053-d805fe0acbaa
|
198
|
|
The expression of growth hormone releasing hormone (GHRH) and its receptors in breast carcinomas with apocrine differentiation - further evidence of the presence of a GHRH pathway in these tumors, file e27ce42b-9174-2581-e053-d805fe0acbaa
|
197
|
|
The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients, file e27ce42c-1d78-2581-e053-d805fe0acbaa
|
180
|
|
Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues, file e27ce427-392b-2581-e053-d805fe0acbaa
|
176
|
|
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues, file e27ce42b-cf8e-2581-e053-d805fe0acbaa
|
174
|
|
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies., file e27ce426-e46d-2581-e053-d805fe0acbaa
|
173
|
|
A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility study, file e27ce426-f22a-2581-e053-d805fe0acbaa
|
170
|
|
Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology, file e27ce42b-980a-2581-e053-d805fe0acbaa
|
168
|
|
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid, file e27ce42e-dbd1-2581-e053-d805fe0acbaa
|
164
|
|
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization, file e27ce42b-cd87-2581-e053-d805fe0acbaa
|
159
|
|
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells., file e27ce427-0885-2581-e053-d805fe0acbaa
|
158
|
|
Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box, file e27ce42b-9812-2581-e053-d805fe0acbaa
|
157
|
|
Inclusion of platinum agents in neoadjuvant chemotherapy regimens for triple-negative breast cancer patients: Development of GRADE (grades of recommendation, assessment, development and evaluation) recommendation by the Italian association of medical oncology (AIOM), file e27ce42f-1984-2581-e053-d805fe0acbaa
|
154
|
|
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer., file e27ce426-e92c-2581-e053-d805fe0acbaa
|
151
|
|
miR-221/222 control luminal breast cancer tumor progression by regulating different targets, file e27ce42a-5807-2581-e053-d805fe0acbaa
|
148
|
|
High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast, file e27ce42d-320a-2581-e053-d805fe0acbaa
|
148
|
|
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling, file e27ce426-fe7e-2581-e053-d805fe0acbaa
|
146
|
|
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study, file e27ce427-0237-2581-e053-d805fe0acbaa
|
145
|
|
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers, file e27ce42e-0873-2581-e053-d805fe0acbaa
|
135
|
|
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene, file e27ce42b-d57f-2581-e053-d805fe0acbaa
|
127
|
|
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study, file e27ce426-adf9-2581-e053-d805fe0acbaa
|
125
|
|
Assessment of a High Sensitivity Method for Identification of IDH1 R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients, file e27ce42d-fcca-2581-e053-d805fe0acbaa
|
118
|
|
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes, file e27ce42c-3ad5-2581-e053-d805fe0acbaa
|
111
|
|
Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast, file e27ce42b-79fb-2581-e053-d805fe0acbaa
|
106
|
|
ESR1 mutations in metastatic lobular breast cancer patients, file e27ce42e-3617-2581-e053-d805fe0acbaa
|
103
|
|
Rediscovering secondary tumors of the prostate in the molecular era, file e27ce42b-a515-2581-e053-d805fe0acbaa
|
98
|
|
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor, file e27ce42d-8bae-2581-e053-d805fe0acbaa
|
95
|
|
SF3B1mutations constitute a novel therapeutic target in breast cancer, file e27ce427-023b-2581-e053-d805fe0acbaa
|
94
|
|
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast, file e27ce42d-5227-2581-e053-d805fe0acbaa
|
88
|
|
The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas, file e27ce430-7e2f-2581-e053-d805fe0acbaa
|
88
|
|
AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells, file e27ce431-b737-2581-e053-d805fe0acbaa
|
88
|
|
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?, file e27ce431-b677-2581-e053-d805fe0acbaa
|
86
|
|
Next-generation learning and training: The Cy-TEST experience, file e27ce42d-471b-2581-e053-d805fe0acbaa
|
81
|
|
Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study, file e27ce42e-eeb1-2581-e053-d805fe0acbaa
|
81
|
|
Tissues under-vacuum to overcome suboptimal preservation, file e27ce42f-267e-2581-e053-d805fe0acbaa
|
78
|
|
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment, file e27ce42d-320c-2581-e053-d805fe0acbaa
|
72
|
|
Synthetic lethality screening highlights colorectal cancer vulnerability to concomitant blockade of nedd8 and egfr pathways, file e27ce432-6e6c-2581-e053-d805fe0acbaa
|
72
|
|
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study, file e27ce42a-4dda-2581-e053-d805fe0acbaa
|
70
|
|
Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer, file e27ce430-aefd-2581-e053-d805fe0acbaa
|
69
|
|
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research, file e27ce42e-eeb0-2581-e053-d805fe0acbaa
|
67
|
|
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer, file e27ce431-8051-2581-e053-d805fe0acbaa
|
67
|
|
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification, file e27ce427-8a95-2581-e053-d805fe0acbaa
|
66
|
|
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas, file e27ce431-578a-2581-e053-d805fe0acbaa
|
65
|
|
Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal, file e27ce431-8202-2581-e053-d805fe0acbaa
|
65
|
|
Pursuit of Gene Fusions in Daily Practice: Evidence from Real-World Data in Wild-Type and Microsatellite Instable Patients, file e27ce432-e4cb-2581-e053-d805fe0acbaa
|
64
|
|
Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma, file e27ce42b-70d4-2581-e053-d805fe0acbaa
|
63
|
|
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors, file e27ce42b-846a-2581-e053-d805fe0acbaa
|
62
|
|
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis., file e27ce426-e932-2581-e053-d805fe0acbaa
|
61
|
|
Breast carcinomas with low amplified/equivocal HER2 by Ish: Potential supporting role of multiplex ligation-dependent probe amplification, file e27ce42d-5225-2581-e053-d805fe0acbaa
|
59
|
|
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study, file e27ce431-71e2-2581-e053-d805fe0acbaa
|
58
|
|
Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses, file e27ce432-360c-2581-e053-d805fe0acbaa
|
55
|
|
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas, file e27ce432-759d-2581-e053-d805fe0acbaa
|
53
|
|
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression, file e27ce42b-c444-2581-e053-d805fe0acbaa
|
49
|
|
PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer, file e27ce432-96c1-2581-e053-d805fe0acbaa
|
49
|
|
Intra-Tumour Heterogeneity Is One of the Main Sources of Inter-Observer Variation in Scoring Stromal Tumour Infiltrating Lymphocytes in Triple Negative Breast Cancer, file e27ce432-360a-2581-e053-d805fe0acbaa
|
47
|
|
Tumoral Neuroligin 1 Promotes Cancer–Nerve Interactions and Synergizes with the Glial Cell Line-Derived Neurotrophic Factor, file e27ce434-7d23-2581-e053-d805fe0acbaa
|
47
|
|
Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases, file e27ce432-31e6-2581-e053-d805fe0acbaa
|
41
|
|
HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast, file e27ce432-3317-2581-e053-d805fe0acbaa
|
38
|
|
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas, file e27ce427-ebbe-2581-e053-d805fe0acbaa
|
34
|
|
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function, file e27ce433-8b6e-2581-e053-d805fe0acbaa
|
34
|
|
Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications, file e27ce42b-a746-2581-e053-d805fe0acbaa
|
32
|
|
The genetic landscape of breast carcinomas with neuroendocrine differentiation, file e27ce42b-bc47-2581-e053-d805fe0acbaa
|
31
|
|
Collision of germline POLE and PMS2 variants in a young patient treated with immune checkpoint inhibitors, file e27ce435-11c1-2581-e053-d805fe0acbaa
|
31
|
|
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function, file e27ce42c-2bcd-2581-e053-d805fe0acbaa
|
30
|
|
Special issue: Molecular biomarkers in solid tumors, file e27ce432-9370-2581-e053-d805fe0acbaa
|
30
|
|
Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement, file 73485947-2dda-4fc1-8928-1a73d449dd60
|
29
|
|
Reccomendations for using of molecular assays on liquid biopsy: The first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC, file e27ce431-b67c-2581-e053-d805fe0acbaa
|
29
|
|
THE EXPRESSION OF LINE1-MET CHIMERIC TRANSCRIPT IDENTIFIES A SUBGROUP OF AGGRESSIVE BREAST CANCERS, file e27ce434-3cba-2581-e053-d805fe0acbaa
|
25
|
|
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family, file e27ce42d-3e14-2581-e053-d805fe0acbaa
|
24
|
|
CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report, file e27ce42d-5234-2581-e053-d805fe0acbaa
|
22
|
|
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance, file e61b9084-f49d-4af2-9203-f2bd324869f9
|
22
|
|
Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast, file e27ce427-bba5-2581-e053-d805fe0acbaa
|
21
|
|
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies, file e27ce435-4824-2581-e053-d805fe0acbaa
|
17
|
|
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family, file e27ce42b-9b1a-2581-e053-d805fe0acbaa
|
14
|
|
HER2 copy number and resistance mechanisms in patients with HER2-positive advanced gastric cancer receiving initial trastuzumab-based therapy in JACOB trial, file 87e000eb-c317-4ed5-89ba-d74138787577
|
12
|
|
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial, file c692a1ce-a732-4420-b13d-5160454ff92d
|
12
|
|
PARP-inhibitors for BRCA1/2-related advanced HER2-negative breast cancer: A meta-analysis and GRADE recommendations by the Italian Association of Medical Oncology, file 9d44bc5b-0bca-4aae-994c-cd90f40d5aee
|
10
|
|
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers, file e27ce42b-ccff-2581-e053-d805fe0acbaa
|
10
|
|
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas, file e27ce435-9762-2581-e053-d805fe0acbaa
|
10
|
|
Medullary Breast Carcinoma, a Triple-Negative Breast Cancer Associated with BCLG Overexpression, file e27ce42d-53d9-2581-e053-d805fe0acbaa
|
9
|
|
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group, file e27ce435-510b-2581-e053-d805fe0acbaa
|
8
|
|
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST, file 69ddea7c-dc59-446c-bde7-e9bd7e699410
|
7
|
|
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer, file e27ce42b-6c4b-2581-e053-d805fe0acbaa
|
7
|
|
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits, file e27ce42f-0282-2581-e053-d805fe0acbaa
|
7
|
|
Integrative genomic and transcriptomic analyses illuminate the ontology of HER2-low breast carcinomas, file eb1e05d7-1b89-421e-a88c-dd4a3753d90e
|
7
|
|
“Borderline” epithelial lesions of the breast: What have we learned in the past three decades?, file e27ce435-3131-2581-e053-d805fe0acbaa
|
6
|
| Totale |
10.621 |